Sector

All

Cyber

Digital Biology

Alternative

Energy

Other

Location

All

Americas

EMEA

APAC

Rest of World

Home > Portfolio > Constructive Bio

Location:

Cambridge, UK

Initial Investment Date:

August 2024

Investment Status:

Current

Pioneering the future of genome writing

Constructive Bio is leveraging the world’s first fully synthetic genome with expanded genetic code to build biomolecules never before possible. They are the global leader in genetic code expansion and the use of novel building blocks of biomolecules to develop better medicines, enzymes, and biomaterials.